Join PharmaJungle & connect with verified pharma buyers Register Free
The Biosimilars Workshop: Innovation and Access in Health will bring together specialists and institutions in Havana to present Rituximab, foster partnerships, and analyze the international outlook for these medicines.
This is a short summary. The full story is published by Telesurenglish.
Read full story at Telesurenglish
The agreement covers injectables, tablets and biosimilars. ADCAN also plans UAE laboratory capacity for monoclonal-antibody quality testing.
Companies like Sandoz and Formycon will significantly expand their portfolios
Swiss pharma firm Sandoz highlights potential savings Ireland could make on medicines bill
The partnership will be supported from a 125,000 sqm site in KEZAD, Abu Dhabi
Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.
Exclusive introductory offer for new advertisers
Get offers from suppliers
Your product details and requirements may be published on the marketplace.
Fields marked with * are mandatory.